|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191.00 KRW | +5.52% |
|
+4.37% | -26.54% |
| 25-10-01 | Investors left reading tea leaves |  |
| 25-08-25 | Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index | CI |
Company Valuation: Abpro Bio Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 142,117 | 461,443 | 244,023 | 115,496 | 155,155 | 128,110 |
| Change | - | 224.69% | -47.12% | -52.67% | 34.34% | -17.43% |
| Enterprise Value (EV) 1 | 171,895 | 441,953 | 211,443 | 104,603 | 147,080 | 128,505 |
| Change | - | 157.11% | -52.16% | -50.53% | 40.61% | -12.63% |
| P/E ratio | -2.94x | -6.28x | -22.3x | -13.9x | -5.89x | -7.86x |
| PBR | 1.1x | 3.32x | 1.83x | 0.82x | 1.27x | 1.19x |
| PEG | - | -0.92x | 0.3x | 0.5x | -0x | 0.2x |
| Capitalization / Revenue | 4.45x | 9.36x | 7.41x | 5.22x | 6.11x | 4.05x |
| EV / Revenue | 5.38x | 8.97x | 6.42x | 4.73x | 5.8x | 4.06x |
| EV / EBITDA | -6.69x | -556x | -78.1x | -10.7x | -17.7x | -25.4x |
| EV / EBIT | -5.7x | -55x | -39.6x | -9.35x | -14.5x | -19.6x |
| EV / FCF | -7.42x | 33.4x | -16.6x | -15.6x | -21.9x | -6.67x |
| FCF Yield | -13.5% | 2.99% | -6.02% | -6.42% | -4.56% | -15% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -273.4 | -292.1 | -43.31 | -30.36 | -92.51 | -57.27 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 31,930 | 49,282 | 32,914 | 22,112 | 25,375 | 31,663 |
| EBITDA 1 | -25,686 | -794.6 | -2,708 | -9,791 | -8,305 | -5,059 |
| EBIT 1 | -30,149 | -8,043 | -5,333 | -11,193 | -10,175 | -6,543 |
| Net income 1 | -35,694 | -58,972 | -10,030 | -8,145 | -25,742 | -15,629 |
| Net Debt 1 | 29,778 | -19,491 | -32,581 | -10,893 | -8,075 | 395.6 |
| Reference price 2 | 804.00 | 1,835.00 | 965.00 | 422.00 | 545.00 | 450.00 |
| Nbr of stocks (in thousands) | 176,762 | 251,468 | 252,874 | 273,688 | 284,688 | 284,688 |
| Announcement Date | 3/13/20 | 3/22/21 | 3/31/22 | 3/23/23 | 3/21/24 | 3/20/25 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 37.36M | |
| 18.22x | 1.59x | 8.92x | 1.94% | 3.13B | |
| 19.91x | 1.26x | 11.79x | 3.24% | 2.93B | |
| 31.91x | 1.96x | 19.23x | 0.38% | 2.6B | |
| 649.44x | - | - | - | 2.39B | |
| 33.28x | - | - | - | 2.13B | |
| 13.52x | 2.59x | 8.84x | 2.68% | 2.1B | |
| Average | 127.71x | 1.85x | 12.20x | 2.06% | 2.19B | |
| Weighted average by Cap. | 121.26x | 1.79x | 12.17x | 2.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- A195990 Stock
- Valuation Abpro Bio Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
